Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients (VANCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02578641
Recruitment Status : Active, not recruiting
First Posted : October 19, 2015
Last Update Posted : March 8, 2021
Sponsor:
Information provided by (Responsible Party):
Tessa Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : January 2023